NVS Cost of Revenue

Novartis AG Common Stock · Cost of Revenue

NVS logo

NVS Cost of Revenue

Latest reported$14.22B
NVS Cost of Revenue ($7.31B → $14.22B)
High-resolution chart · PNG

NVS cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
13,689,746,000
12,827,000,000
12,472,000,000
11,582,000,000
11,735,000,000
15,121,000,000
14,425,000,000
14,510,000,000
13,633,000,000
17,520,000,000
17,404,000,000
17,345,000,000
16,579,000,000
15,866,000,000
18,983,000,000
14,488,000,000
12,179,000,000
11,439,000,000
11,032,000,000
9,411,000,000
7,439,000,000
6,700,000,000
6,457,000,000
4,994,000,000
4,744,000,000
6,346,000,000
5,220,000,000
7,305,233,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.